The North America valganciclovir market is expanding steadily as the region continues to strengthen transplant medicine and infection prevention strategies. Increasing adoption of antiviral therapies, well-established healthcare systems, rising organ transplantation rates, and growing awareness of cytomegalovirus (CMV) management are key factors driving the regional market's growth. Market...